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HIV infection is the main driver of the HIV/tuberculosis (TB) syndemic in southern Africa since the early
1990s, when HIV infection rates started to increase exponentially and TB incidence rates quadruplet
simultaneously. Here, we discuss pathogenic mechanisms of HIV-induced CD4 T-cell depletion and their
potential impact on immune control of Mycobacterium tuberculosis.
Recent findings
Depletion of effector memory CD4 T cells from the air–tissue interphase, their dysfunctional regeneration
and the preferential depletion of MTB-specific CD4 T cells from circulation and from the air–tissue
interphase might be key factors for the increased susceptibility to develop active TB after HIV infection.
Summary
Early initiation of antiretroviral therapy or the development of an efficacious HIV vaccine would be the best
options to reduce morbidity and mortality associated with the HIV/TB syndemic.
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Originating from multiple zoonotic transmissions
of simian immunodeficiency virus (SIV) to humans
in west and central Africa, HIV-1 started to spread in
the early 1900s into larger populations. The most
successful branch of HIV, group M was transmitted
from the chimpanzee Pan troglodytes troglodytes in
which it is endemic [1]. Initially, the spread of HIV-1
group M was geographically confined to western–
central Africa, but international migration and
travel enabled a successful spread across the world
in the second half of the 20th century. Since its
discovery, as the causative agent of the AIDS in 1983
[2,3], HIV prevalence rates have increased steadily
on a global scale to 33 million infected patients –
0.8% of the adult population – in 2009 [4]. Themost
dramatic increase in HIV prevalence rates was
observed in sub-Saharan African countries and an
estimated 68% of globally HIV-infected people live
in sub-Saharan Africa. Particularly, South African
countries are at the ‘epicenter’ of the HIV epidemic,
with adult prevalence rates of up to 25% population
[4].
Globally, active tuberculosis (TB) remains
among the leading causes of death from aninfectious agent. In 2010, the estimated global TB
incidence rate was 128 cases per 100000 population,
which equates to 8.8million (range, 8.5–9.2million)
incident TB cases [5]. Since the 1990s, the worldwide
TB incidences have developed quite divergently.
Whereas in most parts of the world TB incidence
rates remained stable or declined, African incidence
rates increasedbyalmost30%.This increasewasmost
pronounced in Southern Africa, especially South
Africa where the incidence nearly quadrupled to
981 cases per 100000 population (95% uncertainty
interval 806–1170). HIV/TB coinfection numbers
(Fig. 1; red line) indicate that in these countries a
large proportion of the TB incidence is related toVolume 7  Number 3  May 2012
KEY POINTS
 Mycobacterium tuberculosis (MTB) specific CD4 Th1-
cell responses are critical for immune control of
tuberculosis in the murine MTB infection model.
 Effector memory CD4 T cells within the primary site of
MTB infection – the air–tissue interphase of the lung –
are a major target for depletion after AIDS
virus infection.
 The extent of CD4 T-cell depletion from the air–tissue
interphase during acute simian immunodeficiency
virus infection is associated with early disease
reactivation in macaques with latent MTB infection.
 MTB-specific CD4 T cells are preferentially
depleted from circulation and from the air–tissue
interphase in TB asymptomatic patients after
HIV infection.
 Depletion of CD4 T cells, particularly effector
memory CD4 T cells and MTB-specific CD4 T cells
within the air–tissue interphase, might be a key factor
in the impaired control of MTB infection after
HIV infection.
Interaction between the HIV and Mycobacterium tuberculosis Geldmacher et al.immunodeficiency caused by HIV infection. In
South Africa, approximately 60% of TB incident
cases are HIV infected and in total the African
region accounts for 82% of TB cases among people
living with HIV [5]. The dramatic mortality of this
co-epidemic in Southern Africa is highlighted by
a recent postmortem study of young inpatients
(18–45 years) of a hospital in KwaZulu-Natal that
found that 94% were HIVþ and 69% of them had
active TB or were currently on TB treatment at the
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FIGURE 1. Estimated tuberculosis incidence rates, 1990–20
(TB) incidence rates (green) and estimated incidence rates of HIV-
Figure was adapted and modified from the WHO Report 2011 G
1746-630X  2012 Wolters Kluwer Health | Lippincott Williams & WilkiThe HIV-related factors that contribute to the
increased prevalence of active TB in HIV high-
endemic areas are obvious. An impaired immune
system will change the acquisition rate of infection
following exposure. Similarly will the loss of
immune control influence the rate of recurrence
of subclinically infected individuals. The pro-
portional contribution of these factors is unclear
and subject of an ongoing debate [7]. There are data
from cohorts that indicate a two-fold to three-fold
increase of active TB disease within the first year
after HIV seroconversion and that is not a direct
function of the depletion of the blood CD4 cells
[8,9]. In a macaque model for HIV-induced TB reac-
tivation, eight of eight macaques, who were latently
infected with MTB, reactivated within less than a
year after infection with a high dose of SIV [10
&&
].
Here, we discuss how the depletion of memory
CD4 T cells and MTB-specific CD4 T cells after HIV
infection could contribute to loss of MTB immune
control.IMMUNITY TO MYCOBACTERIUM
TUBERCULOSIS INFECTION
Infection with MTB is caused by aerosolic trans-
mission and primarily targets the respiratory system.
Immune correlates of protection are best defined in
the murine model. Although not reflecting all
aspects of human TB pathogenesis, it serves as a
good animal model to elucidate fundamental ques-
tions of host–pathogen interaction and immunity
[11,12]; upon inhalation, MTB is phagocytosed by
alveolar macrophages and myloid dendritic cells
(mDCs) [13].MTB is adapted to survive and replicate
intracellularly within the macrophage phagosome.1990 1995 2000 20102005
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Co-infection of poverty related diseases with wormsMTB-infected myloid dendritic cells, which actively
sample the mucosal environment, migrate to the
draining, lymph nodes to support initiation of the
MTB-specific adaptive immune responses [13,14]; a
delay in priming the adaptive immune response is
thought to be critical in establishing bacterial per-
sistence [14,15]. Initial priming of the adaptive
immune response triggers expansion and pheno-
typic and functional maturation of MTB-specific
T cells, which recirculate and home to the primary
site of infection, in which they activate infected
macrophages through the secretion of interferon
gamma (IFN-g) and tumor necrosis factor alpha
(TNF a) [16
&&
,17]. These Th1 cytokines are important
mediators for arresting intraendosomal MTB
growth, for microbial killing and, perhaps most
importantly, for granuloma formation and matu-
ration [12,18]. In addition, IFN-g-/TNF-independent
T-cell-mediated effector mechanisms also contrib-
ute to the control of MTB [16
&&
,19]. The TB gran-
uloma is the hallmark of the MTB-specific immune
response and locally restricts mycobacterial spread
both in humans and in mice [12,20]. Murine studies
using advanced dynamic imaging methodology
have shown a surprisingly mobile CD4 T-cell popu-
lation during early granuloma formation and
only low frequencies of IFN-g secreting myco-
bacteria-specific CD4 T cells (5–8%) at a given
time point [16
&&
,21]. Indeed, during these early
stages of granuloma formation, the T cells sur-
rounding the mycobacteria are somehow reminis-
cent of riot police kettling tactics to contain street
protests.
MTB-specific CD4 T-cell responses play a central
role in the control of aerosolic MTB infection
[15,17,22,23]; Antibody-mediated depletion of
CD4 T cells but not CD8 T cells, slightly reminiscent
of HIV pathogenesis, drastically reduces control of
MTB growth and survival upon challenge of mice
[24]. Perhaps most conclusive, adoptive transfer of
transgenic MTB-specific CD4 Th 1 cells potently
restricts MTB growth in the lungs of recipient mice
in a dose-dependent manner [17]. Thus, although
CD4 T-cell independent mechanisms are likely to
contribute to microbial immunity, CD4 T cells are
key in the control of murine MTB infection.
Protective immunity against human TB
remains poorly characterized. Human genetic
mutations in IL-12p40 or IFN-g receptor genes
[25] or treatment with TNF antagonists [26] are
associated with a greater risk of TB disease pro-
gression, consistent with a central role of ‘TH1
cytokines’ for efficient control of MTB infection
also in humans. Nonhuman primate experiments
not only support an important role for CD4 T cells
[10
&&
,27] but also suggest a more prominent role270 www.co-hivandaids.comfor CD8 T cells, which include nonclassical CD8
T cells found in humans, but not in mice [28].
Thus, impaired control of MTB infection after
HIV infection still provides the best evidence for
an important role of CD4 T cells in human anti-
MTB immunity.AIDS VIRUS-INDUCED DEPLETION OF CD4
T CELLS FROM THE AIR–TISSUE
INTERPHASE IN THE LUNG
Loss of CD4 T cells during HIV disease progression is
brought on by persistent viral replication. Interfer-
ing with viral replication by highly active antiretro-
viral therapy (HAART) initiation reconstitutes CD4
T-cell counts, largely restores pathogen-specific CD4
T-cell responses and substantially decreases the risk
of developing active TB [29–31]. CCR5-tropic virus
variants are responsible for most transmission
events and typically prevail until late phase of infec-
tion [32]. During natural HIV infection, CXCR4
tropism evolves only relatively late in infection after
CD4 T-cell numbers have dropped substantially [33]
and is associated with infection and depletion of
naive CD4 T cells [34]. Thus, early loss of MTB
immune control should usually be linked to CCR5
tropism and selective targeting CCR5þ CD4 T cells;
CCR5 expression is characteristic of effector mem-
ory CD4 T cells isolated frommucosal tissues includ-
ing the lung [35–37] and can be induced by
antigenic stimulation and activation of CD4 T cells
in vitro [38], but is largely absent from naive CD4
T cells. CCR5-tropic viruses preferentially infect and
replicate in activated memory CD4 T cells that
express the chemokine receptor CCR5 and these
cells are preferentially depleted after AIDS virus
infection [35]. Pathogenesis of CCR5-tropic virus
infection has been intensively studied after exper-
imental infection of simian rhesus macaques with
SIVs – a goodmodel for humanHIV infection. Both,
acute and chronic SIV and HIV infection results in
extensive depletion of effector memory CD4 T cells
from mucosal effector sites, [39–42] including the
tissue–air interphase of the lung [36,43]. Hence,
effector memory CD4 T cells at the primary site of
aerosolicMTB infection, are also a primary target for
depletion after infection with CCR5 tropic viruses
and the timing of their depletion after SIV infection
is associated with reactivation of MTB infection in
macaques [10
&&
]. Influx of newly generated CD4
T effector memory cells can partially replenish
CD4 T cells in the air–tissue interphase, despite their
reduced life span during SIV infection [36,43,44].
Increased cellular turn over and maturation of
central memory into effector memory CD4 T cells
are responsible for continuous renewal of thisVolume 7  Number 3  May 2012
Interaction between the HIV and Mycobacterium tuberculosis Geldmacher et al.effector memory T-cell population and probably
simultaneously promote AIDS virus replication in
transitional CD4 T cells [45,46], resulting in a net
loss of effector memory CD4 T-cell output from
secondary lymphoid organs. Progressive loss of
the capacity for renewal of this effector memory
CD4 T-cell pool is thought to be central to the
pathogenesis AIDS virus infection [43]. Substantial
and progressive depletion of CD4 T cell within
tissue–air interphase is also characteristic of chronic
HIV-infected humans [47
&&
,48
&&
,49
&
]. Human tis-
sue–air interphase CD4 T cells are effector memory
T cells as characterized by a CD45RACCR7CD27
phenotype [47
&&
,48
&&
]. Blocking virus replication by
HAART initiation reverses CD4 T-cell depletion
within tissue–air interphase [49
&
] and reduces the
risk of developing active TB by at least 70% [29].
Together, these data demonstrate that the site of
primary MTB infection is particularly vulnerable to
AIDS virus-induced immune defects.
The timing of effector memory CD4 T-cell
depletion from the air–tissue interphase after SIV
infection is associated with reactivation of MTB
infection [10
&&
], suggesting that HIV infection can
reduce efficacy of the protective properties of an
existing granuloma [50
&
]. This finding is supported
by histological studies that found differences in
the cellular composition, architecture and func-
tion of MTB granulomas associated with HIV infec-
tion, such as fewer mononuclear cells, fewer CD4
T cell [51,52], perturbations in TNF expression and
larger areas of necrosis [51,53]. A more recent study
found no such morphological alterations in granu-
lomas during pleural TB during earlier HIV disease
stages [53]. Interestingly, granulocyte involvement
appears to be increased granulomas from HIVþ
patients, resembling a pattern also observed in
MTB-infected CD4 knockout mice [11,23,51]. In
summary, relatively little information is known
about HIV interference with the MTB granuloma.
The pathogenic mechanisms of AIDS virus-induced
granuloma dysfunction need further clarification.DYNAMICS OF MYCOBACTERIUM
TUBERCULOSIS-SPECIFIC CD4 TH1-CELL
RESPONSES AFTER HIV INFECTION
The timing of disease caused by opportunistic infec-
tions is not strictly related to the extent of CD4 T-cell
depletion for a given pathogen. HIV-associated
changes in the quantity or quality of opportunistic
pathogen-specific CD4 T-cell responses could poten-
tially contribute to increased susceptibility to a given
pathogen [54]. For example, clinical complications
caused by cytomegalovirus (CMV) closely correlates
with depletion of CMV-specific CD4 T-cell responses1746-630X  2012 Wolters Kluwer Health | Lippincott Williams & Wilki[55–57]. Similarly, in SIV/bacillus Calmette-Gue´rin
coinfected rhesus macaques reactivation of tuber-
culosis-like disease coincides with waning myco-
bacterial-specific T-cell proliferative responses [27].
Several studies, including our own, have recently
shown that MTB-specific CD4 T-cell responses are
preferentially depleted after HIV infection from
circulation and also from the tissue–air interphase
[47
&&
,48
&&
,58
&
] suggesting that MTB-specific immun-
ity is particularly vulnerable to HIV-induced defects.
These data support the hypothesis that a reduction in
the generation of lung homingMTB-specific effector
memory CD4 Th1 cells after HIV infection is a key
factor in the increase risk for development of active
TB (Fig. 2).
The reasons for differential depletion of different
pathogen-specific CD4 T cells after HIV infection are
probably multifactorial. Phenotypic and functional
properties of MTB-specific CD4 T cells, such as sur-
face expression of CCR5 [59], a low capacity to
secrete ‘protective’ CCR5 ligand MIP-1b and large
capacity for interleukin (IL) 2-dependent T-cell pro-
liferation promote cellular HIV infection in vitro and
in vivo [58
&
,59–61]. And indeed,MTB-specific CD4 T
cells have significantly higher cell-associated viral
loads in vivo as compared with total memory CD4 T
cells during active TB [58
&
]. Activated mycobacteria-
specific CD4 T-cell responses strongly promote HIV
replicationboth in vitro [60] and in vivo [62,63]. These
data support a model in which a combination
of proinflammatory cytokines and cell-contact
dependent costimulatory interactions maximize
transcription of the HIV genome and production
of virions in HIV-infected antigen-presenting cells,
which transmit to responding CCR5þ, proliferating
MTB-specific CD4 T cells [64,65] Refer to Fig. 4/2.
Such a scenario would depend on ongoing MTB-
specific stimulation of CD4 T cells during latency. A
continuous crosstalk between the host immune
system and the persisting pathogens [66] would
support such a model.
However, the level of antigenic stimulation
during MTB latency is unclear and probably varies
between individuals. Loss of MTB-specific CD4
T-cell response rather argues against strong antigenic
stimulation after HIV infection, because, somehow
counterintuitive,MTB-specific CD4 T cells can often
be detected in HIV-positive patients with active TB,
most probable due to antigen-driven CD4 T-cell
expansion counteracting (or concealing) depletion.
Persistent or expandingMTB responses after HIV and
SIV infection have indeed rather been associated
with subsequent progression [59,67,68]. As a con-
sequence, it is difficult to dissect the effects of AIDS
virus-associated CD4 T-cell depletion in the presence
of strong antigen-driven cellular CD4 T-cellns www.co-hivandaids.com 271
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FIGURE 2. Proposed mechanism of how HIV-induced CD4 T-cell depletion impairs immune control of MTB infection.
1, Infection of airways with MTB (red rods); the bacilli are taken up by alveolar macrophages (pale orange) and dendritic
cells (DCs, dark orange). MTB-infected DCs then migrate to the thoracic lymph nodes to trigger the adaptive MTB-specific CD4
T-cell response. Some MTB-infected DCs are coinfected with HIV. 2, Within the lymph node, HIV is efficiently transferred from
DCs to MTB-specific CD4 T cells that respond to cognate antigen. DC–T-cell interaction maximizes HIV virion production in
antigen-presenting cells and simultaneously increases CCR5 expression by activated MTB-specific CD4 T cells (pink). IL-2-
dependent cell cycling promotes complete reverse transcription of the viral RNA genome and as a consequence productive
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Interaction between the HIV and Mycobacterium tuberculosis Geldmacher et al.expansion during reactivating TB. In the majority of
‘latently’ infected humans, T-cell stimulation appa-
rently is insufficient to maintain MTB-specific CD4
T-cell responses after HIV infection, implying that
other protective mechanisms, such as ‘hermetically
sealed granulomas’ or other immune cell subsets [28]
might contain MTB replication. Alternatively, the
presence of MTB-specific T-cell memory might
not necessarily equate with reactivatable disease
[29,69,70]. Epidemiological studies are divided: some
studies argue rather for novo exposure as compared
with reactivation as a frequent cause of HIV-associ-
ated active TB inhigh-burden settings of sub-Saharan
Africa [7], whereas a recent study shows a five-fold
increased TB incidence of HIVþ/interferon gamma
release assay positive (IGRAþ) patients (5%) com-
pared with HIVþ/IGRA patients (<1%), supporting
latent MTB reactivation as an important cause for
active TB in HIV patients [71]. Thus, both mechan-
isms are likely to play a role. However, it is tempting
to speculate that recent exposure and early granu-
loma formation and maturation is more likely to be
affected by HIV interference, as compared with old,
mature, ‘fibrotic and calcified’ lesions, which might
restrict bacterial disseminationmore independent of
T-cell effector function.CONCLUSION
In conclusion, AIDS virus infection interferes with
the generation of effector memory CD4 T cell that
migrate to the primary site of MTB infection – the
lung – and dramatically increases risk of developing
active TB. Moreover, MTB-specific CD4 T-cell
responses are selectively depleted both, in circula-
tion and at the air–tissue interphase of the lung, and
probably further aggravating the failure of the
immune system to efficiently control MTB after
HIV infection. Other ‘more global’ immune defects
brought on by persistent viral replication, such as
persistent immune activation or dysfunction and
depletion of antigen-presenting cells, are also likely
to promote TB disease progression in HIV-infectedFIGURE 2. (Continued ) HIV infection of MTB-specific CD4 T cel
productively infected cells also die as a result of abortive HIV infe
effector memory and particularly MTB-specific CD4 T cells. 4, MT
of MTB infection. HIV reduces the overall number of lung homing
EM CD4 T cells. As a consequence, T-cell-mediated granuloma fo
impaired leading to an increased risk to develop active TB upon n
lung homing MTB-specific EM CD4 TH1 cells and shortens cell su
granuloma formation, maturation and thus the control of MTB infe
active TB upon new MTB infection. 4B, In HIV-infected humans wi
CD4 TH1 cells decreases functionality of the MTB granuloma and
the risk of systemic dissemination of MTB infection. It can be spec
MTB infection more independently from CD4 T-cell depletion.
1746-630X  2012 Wolters Kluwer Health | Lippincott Williams & Wilkiindividuals. Hence, at this point in time, early
initiation of antiretroviral therapy or the develop-
ment of an efficacious HIV vaccinewould be the best
options to reduce morbidity and mortality associ-
ated with this co-epidemic.Acknowledgements
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